Strategy

ANTO Embarks on a Journey, Initiating a New Era in Cryptocurrency Asset Management

Retrieved on: 
Dienstag, April 16, 2024
Financial management, ETF, Exchange-traded fund, Strategy, Investment, Safety, Cryptocurrency

ANTO provides secure and robust digital asset investment services for global investors, aiming to create more opportunities for wealth growth.

Key Points: 
  • ANTO provides secure and robust digital asset investment services for global investors, aiming to create more opportunities for wealth growth.
  • As a legitimate and compliant digital asset management platform, ANTO was established in the United States, a country that has legalized cryptocurrencies.
  • By pledging the AE warrants for financial management, investors can easily achieve asset allocation without complex operations, investing without worry.
  • ANTO believes that with its services and support, investors will be able to achieve their financial goals and embark on a new era of digital asset investment.

KalVista Pharmaceuticals Highlights Strategic Plans for Coming Fiscal Year

Retrieved on: 
Mittwoch, Mai 1, 2024
Research, FDA, Children, Clinical Trials, Health, Consumer, Pharmaceutical, Other Science, Science, Shanda, ACAAI, Conference, Adolescence, KALV, Hereditary angioedema, Patient, EAACI, ODT, Strategy, HAE

(NASDAQ: KALV), today announced its strategic plans for fiscal year 2025, beginning May 1, including for sebetralstat, the Company’s investigational novel, oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema (HAE).

Key Points: 
  • (NASDAQ: KALV), today announced its strategic plans for fiscal year 2025, beginning May 1, including for sebetralstat, the Company’s investigational novel, oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema (HAE).
  • “2024 has been an exciting and busy year for KalVista, as we achieved key milestones with our positive phase 3 KONFIDENT data and the completion of a substantial financing,” said Ben Palleiko, Chief Executive Officer of KalVista.
  • “For the coming fiscal year, we have set a high bar as we finalize multiple regulatory filings for sebetralstat and plan for rapid commercialization upon approval.
  • Therefore, further development of the program will be dependent upon collaboration with a strategic partner with expertise and resources to support advancement of the clinical candidates in these potential indications.

Surge Copper Outlines Pre-Feasibility Technical Work Programs at Berg and Announces Additional Private Placement for up to $1.0 million

Retrieved on: 
Mittwoch, April 10, 2024
Copper, Project, Sale, SURG, PEA, Common, Silver, News, Private, Hydrogeology, Technical report, Molybdenum, TSX, ARM, Indian stock exchange, Gold, Qualified person (European Union), National instrument, Regulation, Soil, Strategy, Sidecar, TSX Venture Exchange, Growth, Person, Private placement

Metallurgy – a test work program will aim to advance bulk copper-molybdenum concentrate flotation parameters and to confirm copper, molybdenum, silver, and gold recovery performance into separate copper and molybdenum concentrates.

Key Points: 
  • Metallurgy – a test work program will aim to advance bulk copper-molybdenum concentrate flotation parameters and to confirm copper, molybdenum, silver, and gold recovery performance into separate copper and molybdenum concentrates.
  • This program is fully scoped and suitable composite sample material is available and awaiting shipment.
  • In the event the maximum number of Side-Car Common Shares are issued under the Side-Car Private Placement, a total of 1,764,705 additional Strategic Placement Common Shares will be purchased by ARM under the Strategic Placement, resulting in total gross proceeds to Surge between the Strategic Placement and the Side-Car Private Placement of approximately $5 million.
  • The net proceeds from the Side-Car Private Placement will be used to fund the advancement of the Berg Project, exploration, and for working capital and general corporate purposes.

Neil Waller and James Street Appointed Co-CEOs of Whalar Group

Retrieved on: 
Donnerstag, April 18, 2024
Content Marketing, Other Communications, Publishing, Marketing, Advertising, Communications, Media, Digital Marketing, Social Media, Influencer, Intelligence, CCO, Creativity, Integration, Heart, Entrepreneurship, James Neil, Digital, Culture, Data, James Street, Creator economy, Strategy, Growth, Management

Neil Waller, Co-CEO and Co-Founder, Whalar Group, said: “James and I have always been entrepreneurs at heart.

Key Points: 
  • Neil Waller, Co-CEO and Co-Founder, Whalar Group, said: “James and I have always been entrepreneurs at heart.
  • James Street, Co-CEO and Co-Founder, Whalar Group, said on the addition of Christoph: “In today's landscape, creators wield immense power and relevance.
  • On joining Whalar Group, Christoph Becker said: “Whalar Group stands as a powerhouse in the Creator Economy, unleashing the creative voices shaping our future business.
  • Whalar Group is a company that is building a culture that celebrates the future of creativity and I’m honored to embark on this liberation journey alongside Neil, James, and the Whalar Group teams.”
    Whalar Group is on a mission to liberate the creative voice.

All Seas Capital Invests in Reducate EdTech Group to Accelerate Growth

Retrieved on: 
Mittwoch, April 17, 2024
Technology, Finance, Business, Professional Services, Other Education, Internet, Continuing, Training, Education, LLP, EY, Strategy, RSM, Partnership, C2 Proficiency, Lincoln International, Educational technology, Growth, Management

All Seas Capital, a pan-European private capital fund that provides transformational capital solutions to leading founder- and entrepreneur-owned companies, announces a significant minority investment in Reducate EdTech Group (“Reducate”), a leading online continuing professional education (“CPE”) platform with strong foundations in the Netherlands and Denmark, to accelerate its European growth strategy.

Key Points: 
  • All Seas Capital, a pan-European private capital fund that provides transformational capital solutions to leading founder- and entrepreneur-owned companies, announces a significant minority investment in Reducate EdTech Group (“Reducate”), a leading online continuing professional education (“CPE”) platform with strong foundations in the Netherlands and Denmark, to accelerate its European growth strategy.
  • Renowned for its unrivalled portfolio of mission-critical, high-quality e-learning courses, Reducate operates through 11 distinct brands, serving over 175,000 professionals across Europe in more than 40 different professions.
  • Henk Makaske, Chief Executive Officer of Reducate, said:
    “As we join forces with All Seas Capital, we are not just starting a new chapter in our story—we are setting the course for European expansion.
  • All Seas Capital was advised by De Breij for legal matters, RSM LLP for financial and tax due diligence, and EY for structuring matters.

Gryphon Adds Business Strategy Veteran Jeff Morton, former founder of ACA Compliance Group, as Senior Advisor

Retrieved on: 
Mittwoch, April 10, 2024
Data Management, Public Policy, Government, Defense, Technology, Security, Small Business, Legal, Insurance, Human Resources, Finance, Consulting, Banking, University, Accounting, Professional Services, Education, White House, Federal Government, State, Local, Health, General Health, Networks, Contracts, ACA, Exchange, Strategy, Growth, Partner (business rank), Privacy, GRC, Strategic planning, Management

Gryphon Strategies, LLC , a global leader in investigations and business intelligence, today announced the appointment of Jeff Morton as a senior advisor to the firm.

Key Points: 
  • Gryphon Strategies, LLC , a global leader in investigations and business intelligence, today announced the appointment of Jeff Morton as a senior advisor to the firm.
  • Morton has deep expertise in strategic planning, business development, process improvement and merger and acquisitions.
  • He will advise on the company’s corporate strategy and business development initiatives as well as help drive service and process improvements, expanding the company’s proposition to its valued clients.
  • Jeff is a highly respected strategic leader whose outstanding financial and business expertise will meaningfully strengthen our leadership,” said Jay Dawdy, President & CEO of Gryphon.

Transmission and Resource Planning Expert Akarsh Sheilendranath Rejoins The Brattle Group as Principal

Retrieved on: 
Dienstag, April 23, 2024
Brattle Group, Policy, Optical disc image, ISO New England, Monolithic kernel, Federal Energy Regulatory Commission, Electricity, Engineering, Strategy

BOSTON, April 23, 2024 /PRNewswire/ -- The Brattle Group has welcomed Akarsh Sheilendranath to its Boston, MA office as a Principal in the firm's Electricity Wholesale Markets & Planning practice.

Key Points: 
  • BOSTON, April 23, 2024 /PRNewswire/ -- The Brattle Group has welcomed Akarsh Sheilendranath to its Boston, MA office as a Principal in the firm's Electricity Wholesale Markets & Planning practice.
  • Mr. Sheilendranath, who previously worked at Brattle and will be based in Houston, specializes in electric transmission, regulatory corporate finance, and resource planning and strategy.
  • "We are thrilled to welcome Akarsh back to Brattle," said Torben Voetmann, Brattle President & Principal.
  • This includes cost of capital and risk assessments, transmission policy, utility resource planning, renewables and electric storage valuation, investment strategy, resource adequacy matters, and electricity market rules and tariffs.

FIFTH WALL NAMES JEREMY FOX & G.M. NICHOLAS VIK CO-PRESIDENTS

Retrieved on: 
Dienstag, April 23, 2024
Credit Suisse, Climate change, Fox, Housing, Hudson Yards, Deutsche Bank, Like a Boss (film), ICONIQ Capital, Knowledge, IPO, Cambridge Associates, Snap Inc., Equity capital markets, Strategy, Management

NEW YORK, April 23, 2024 /PRNewswire/ -- Fifth Wall—the largest asset manager focused on improving, future-proofing, and decarbonizing the built world—announced that Jeremy Fox and G.M. Nicholas "Magnus" Vik have been appointed the Firm's Co-Presidents, a new position, to help guide the company through its next phase of transformational growth.

Key Points: 
  • In tandem with serving as Co-President, alongside Fox, Vik has been appointed Fifth Wall's Chief Operating Officer.
  • Prior to joining Fifth Wall, Vik was Director of Strategy & Finance and a founding member at Renew Health.
  • "In their time at Fifth Wall, Jeremy and Magnus have proven to be highly valuable assets to our team, our Limited Partners, and our Portfolio Companies," said Brad Greiwe , Chairman of Fifth Wall.
  • In addition to Fox and Vik's appointment to Co-Presidents, Fifth Wall has also elevated five other senior team members.

Prescient Healthcare Group Announces the Appointment of Two New Members to Its Board of Directors

Retrieved on: 
Montag, April 22, 2024
University, KPMG, McKinsey & Company, General surgery, Commercial, Heart, Strategy, Growth, Human, Patient, Medicine, Health, Marketing, Melange (fictional drug), AstraZeneca, Management

LONDON, April 22, 2024 /PRNewswire/ -- Prescient Healthcare Group , a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors – Dr. Luke Solon and Debbie Allman – to help shape and drive Prescient's global mission.

Key Points: 
  • LONDON, April 22, 2024 /PRNewswire/ -- Prescient Healthcare Group , a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors – Dr. Luke Solon and Debbie Allman – to help shape and drive Prescient's global mission.
  • He earned his medical degree from the University of Southampton and then spent four years as a practicing physician, predominantly in general surgery.
  • At Prescient, he primarily works with our Medical Affairs clients or on commercial engagements when a more clinical lens is required.
  • "I am very pleased to welcome these new directors to the Board," said Dr. Nicholas Edwards, Chairman.

Prescient Healthcare Group Appoints Two New Members to its Board of Directors

Retrieved on: 
Freitag, April 19, 2024
University, KPMG, McKinsey & Company, General surgery, Commercial, Heart, Strategy, Growth, Human, Patient, Health, Marketing, Melange (fictional drug), AstraZeneca, Management

LONDON, April 19, 2024 /PRNewswire/ -- Prescient Healthcare Group , a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors – Dr. Luke Solon and Debbie Allman – to help shape and drive Prescient's global mission.

Key Points: 
  • LONDON, April 19, 2024 /PRNewswire/ -- Prescient Healthcare Group , a leading biopharma product and portfolio strategy firm, has announced the appointment of two new members to its Board of Directors – Dr. Luke Solon and Debbie Allman – to help shape and drive Prescient's global mission.
  • He earned his medical degree from the University of Southampton and then spent four years as a practicing physician, predominantly in general surgery.
  • At Prescient, he primarily works with our Medical Affairs clients or on commercial engagements when a more clinical lens is required.
  • "I am very pleased to welcome these new directors to the Board," said Dr. Nicholas Edwards, Chairman.